The chromatin-tethering domain of human cytomegalovirus immediate-early (IE) 1 mediates associations of IE1, PML and STAT2 with mitotic chromosomes, but is not essential for viral replication

References

1. Adler M., Tavalai N., Müller R., Stamminger T. 2011; Human cytomegalovirus immediate-early gene expression is restricted by the nuclear domain 10 component Sp100. J Gen Virol 92:1532–1538 [View Article][PubMed]
   [Google Scholar]
2. Ahn J. H., Hayward G. S. 1997; The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J Virol 71:4599–4613[PubMed]
   [Google Scholar]
3. Ahn J. H., Hayward G. S. 2000; Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection. Virology 274:39–55 [View Article][PubMed]
   [Google Scholar]
4. Ahn J. H., Brignole E. J. III, Hayward G. S. 1998; Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML. Mol Cell Biol 18:4899–4913[PubMed]
   [Google Scholar]
5. Dimitropoulou P., Caswell R., McSharry B. P., Greaves R. F., Spandidos D. A., Wilkinson G. W., Sourvinos G. 2010; Differential relocation and stability of PML-body components during productive human cytomegalovirus infection: detailed characterization by live-cell imaging. Eur J Cell Biol 89:757–768 [View Article][PubMed]
   [Google Scholar]
6. Gawn J. M., Greaves R. F. 2002; Absence of IE1 p72 protein function during low-multiplicity infection by human cytomegalovirus results in a broad block to viral delayed-early gene expression. J Virol 76:4441–4455 [View Article][PubMed]
   [Google Scholar]
7. Greaves R. F., Mocarski E. S. 1998; Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus IE1 mutant. J Virol 72:366–379[PubMed]
   [Google Scholar]
8. Huh Y. H., Kim Y. E., Kim E. T., Park J. J., Song M. J., Zhu H., Hayward G. S., Ahn J. H. 2008; Binding STAT2 by the acidic domain of human cytomegalovirus IE1 promotes viral growth and is negatively regulated by SUMO. J Virol 82:10444–10454 [View Article][PubMed]
   [Google Scholar]
9. Kim M. S., Yi H. A., Lee C. H. 2008; Human cytomegalovirus induces intercellular adhesion molecule-1 expression in a monocytic cell line, THP-1. J Bacteriol Virol 38:39–46 [View Article]
   [Google Scholar]
10. Kim Y. E., Lee J. H., Kim E. T., Shin H. J., Gu S. Y., Seol H. S., Ling P. D., Lee C. H., Ahn J. H. 2011; Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expression. J Virol 85:11928–11937 [View Article][PubMed]
    [Google Scholar]
11. Knoblach T., Grandel B., Seiler J., Nevels M., Paulus C. 2011; Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-γ. PLoS Pathog 7:e1002016 [View Article][PubMed]
    [Google Scholar]
12. Korioth F., Maul G. G., Plachter B., Stamminger T., Frey J. 1996; The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp Cell Res 229:155–158 [View Article][PubMed]
    [Google Scholar]
13. Krauss S., Kaps J., Czech N., Paulus C., Nevels M. 2009; Physical requirements and functional consequences of complex formation between the cytomegalovirus IE1 protein and human STAT2. J Virol 83:12854–12870 [View Article][PubMed]
    [Google Scholar]
14. Lafemina R. L., Pizzorno M. C., Mosca J. D., Hayward G. S. 1989; Expression of the acidic nuclear immediate-early protein (IE1) of human cytomegalovirus in stable cell lines and its preferential association with metaphase chromosomes. Virology 172:584–600 [View Article][PubMed]
    [Google Scholar]
15. Le V. T., Trilling M., Wilborn M., Hengel H., Zimmermann A. 2008; Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation. J Gen Virol 89:2416–2426 [View Article][PubMed]
    [Google Scholar]
16. Lee H. R., Kim D. J., Lee J. M., Choi C. Y., Ahn B. Y., Hayward G. S., Ahn J. H. 2004; Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells. J Virol 78:6527–6542 [View Article][PubMed]
    [Google Scholar]
17. Lee H. R., Huh Y. H., Kim Y. E., Lee K., Kim S., Ahn J. H. 2007; N-terminal determinants of human cytomegalovirus IE1 protein in nuclear targeting and disrupting PML-associated subnuclear structures. Biochem Biophys Res Commun 356:499–504 [View Article][PubMed]
    [Google Scholar]
18. Marchini A., Liu H., Zhu H. 2001; Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J Virol 75:1870–1878 [View Article][PubMed]
    [Google Scholar]
19. Marechal V., Dehee A., Chikhi-Brachet R., Piolot T., Coppey-Moisan M., Nicolas J. C. 1999; Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J Virol 73:4385–4392[PubMed]
    [Google Scholar]
20. Mocarski E. S., Kemble G. W., Lyle J. M., Greaves R. F. 1996; A deletion mutant in the human cytomegalovirus gene encoding IE1(491 aa) is replication defective due to a failure in autoregulation. Proc Natl Acad Sci U S A 93:11321–11326 [View Article][PubMed]
    [Google Scholar]
21. Mocarski E. S., Shenk T., Pass R. F. 2007; Cytomegaloviruses. In Fields Virology pp. 2701–2772 Edited by Knipe D. M., Howley P. M., Griffin D. E., Lamb R. A., Martin M. A., Roizman B., Straus S. E. Philadelphia, PA: Lippincott Williams & Wilkins;
    [Google Scholar]
22. Paulus C., Krauss S., Nevels M. 2006; A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling. Proc Natl Acad Sci U S A 103:3840–3845 [View Article][PubMed]
    [Google Scholar]
23. Piolot T., Tramier M., Coppey M., Nicolas J. C., Marechal V. 2001; Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes. J Virol 75:3948–3959 [View Article][PubMed]
    [Google Scholar]
24. Reinhardt J., Smith G. B., Himmelheber C. T., Azizkhan-Clifford J., Mocarski E. S. 2005; The carboxyl-terminal region of human cytomegalovirus IE1491aa contains an acidic domain that plays a regulatory role and a chromatin-tethering domain that is dispensable during viral replication. J Virol 79:225–233 [View Article][PubMed]
    [Google Scholar]
25. Spengler M. L., Kurapatwinski K., Black A. R., Azizkhan-Clifford J. 2002; SUMO-1 modification of human cytomegalovirus IE1/IE72. J Virol 76:2990–2996 [View Article][PubMed]
    [Google Scholar]
26. Tavalai N., Papior P., Rechter S., Leis M., Stamminger T. 2006; Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J Virol 80:8006–8018 [View Article][PubMed]
    [Google Scholar]
27. Tavalai N., Papior P., Rechter S., Stamminger T. 2008; Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J Virol 82:126–137 [View Article][PubMed]
    [Google Scholar]
28. Tavalai N., Adler M., Scherer M., Riedl Y., Stamminger T. 2011; Evidence for a dual antiviral role of the major nuclear domain 10 component Sp100 during the immediate-early and late phases of the human cytomegalovirus replication cycle. J Virol 85:9447–9458 [View Article][PubMed]
    [Google Scholar]
29. Wilkinson G. W., Kelly C., Sinclair J. H., Rickards C. 1998; Disruption of PML-associated nuclear bodies mediated by the human cytomegalovirus major immediate early gene product. J Gen Virol 79:1233–1245[PubMed]
    [Google Scholar]
30. Xu Y., Ahn J. H., Cheng M., apRhys C. M., Chiou C. J., Zong J., Matunis M. J., Hayward G. S. 2001; Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression. J Virol 75:10683–10695 [View Article][PubMed]
    [Google Scholar]